Stock Earnings
UBS analysts upgrades a Neutral rating for Calumet Inc (CLMT)
Calumet Inc’s recently made public that its Officer Mawer Stephen P acquired Company’s shares for reported $46671.0 on Mar 24
Menu
Calumet Inc’s recently made public that its Officer Mawer Stephen P acquired Company’s shares for reported $46671.0 on Mar 24
Arcutis Biotherapeutics Inc’s recent filing unveils that its Officer Watanabe Todd Franklin acquired Company’s shares for reported $26282.0 on Mar
In a filing, Emergent Biosolutions Inc revealed its Director Fowler Neal Franklin unloaded Company’s shares for reported $0.2 million on
Avidity Biosciences Inc’s filing revealed that its Chief Medical Officer Hughes Steven George unloaded Company’s shares for reported $0.3 million
EBay Inc’s recently made public that its SVP, Chief Product Officer Garcia Edward O unloaded Company’s shares for reported $1.2
FibroGen Inc’s recent filing unveils that its Director Schoeneck James A acquired Company’s shares for reported $88000.0 on Mar 20
In a filing, BankUnited Inc revealed its Director SOBTI SANJIV acquired Company’s shares for reported $32830.0 on Mar 13 ’25.
Coupang Inc’s filing revealed that its Director Sun Benjamin unloaded Company’s shares for reported $5.86 million on Mar 17 ’25.
Target Corp’s recently made public that its Executive Officer Cornell Brian C unloaded Company’s shares for reported $5.1 million on
Helix Energy Solutions Group Inc’s recent filing unveils that its EVP, GEN COUNSEL & SECRETARY Neikirk Kenneth English unloaded Company’s